EULAV Asset Management’s Pfizer PFE Stock Holding History

EULAV Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-107,508	Closed	-$4.5M	–	297
2018 Q3	$4.5M	Sell	107,508 -2,108	-2%	-$81.2K	0.19%	134
2018 Q2	$3.77M	Hold	109,616	–	–	0.17%	147
2018 Q1	$3.69M	Buy	109,616 +10,540	+11%	+$362K	0.18%	154
2017 Q4	$3.4M	Sell	99,076 -6,324	-6%	-$216K	0.16%	164
2017 Q3	$3.57M	Sell	105,400 -33,176	-24%	-$1.07M	0.17%	161
2017 Q2	$4.42M	Sell	138,576 -40,604	-23%	-$1.28M	0.22%	145
2017 Q1	$5.82M	Buy	179,180 +83,266	+87%	+$2.63M	0.3%	116
2016 Q4	$2.96M	Sell	95,914 -21,582	-18%	-$659K	0.16%	177
2016 Q3	$3.78M	Buy	+117,496	New	+$3.93M	0.2%	151
2015 Q4	–	Sell	-84,320	Closed	-$2.51M	–	307
2015 Q3	$2.51M	Sell	84,320 -8,841	-9%	-$283K	0.14%	196
2015 Q2	$2.96M	Sell	93,161 -5,270	-5%	-$172K	0.16%	195
2015 Q1	$3.25M	Hold	98,431	–	–	0.17%	192
2014 Q4	$2.91M	Hold	98,431	–	–	0.16%	200
2014 Q3	$2.76M	Hold	98,431	–	–	0.15%	213
2014 Q2	$2.77M	Hold	98,431	–	–	0.15%	208
2014 Q1	$3M	Hold	98,431	–	–	0.16%	191
2013 Q4	$2.86M	Hold	98,431	–	–	0.16%	196
2013 Q3	$2.68M	Sell	98,431 -2,530	-3%	-$68.8K	0.16%	203
2013 Q2	$2.68M	Buy	+100,961	New	+$2.79M	0.16%	201

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EULAV Asset Management's PFE Position: Q4 2018 in Review

EULAV Asset Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 107,508 shares — an estimated $4.5M sold.

EULAV Asset Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $5.82M in Q1 2017. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

EULAV Asset Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
EULAV Asset Management sold 107,508 Pfizer shares in Q4 2018, an estimated $4.5M.
EULAV Asset Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
EULAV Asset Management's Pfizer position peaked at $5.82M in Q1 2017.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on EULAV Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.